Status:
NOT_YET_RECRUITING
Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
Lead Sponsor:
Endogenex, Inc.
Conditions:
Type 2 Diabetes Mellitus (T2DM)
Type2Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.
Detailed Description
This is an observational registry that is designed to facilitate long-term patient follow-up for up to 5 years after an Endogenex procedure. It is structured to enable systematic longitudinal data col...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- Have been treated with the Endogenex System
- Consented to participate in the Endogenex PULSE Registry
Exclusion
- Unwilling or unable to attend study visits
- Unwilling or unable to provide medical records to study sites
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2032
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07197775
Start Date
October 1 2025
End Date
May 1 2032
Last Update
September 29 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.